Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 7, 2007 - Issue 10
Submit an article Journal homepage
144
Views
32
CrossRef citations to date
0
Altmetric
Drug Profile

Bevacizumab in the treatment of ovarian cancer

Ernest S Han Clinical Instructor, University of California Irvine, Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, Orange, CA 92868, USA. [email protected]
&
Bradley J Monk Associate Professor, University of California Irvine, Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, Orange, CA 92868, USA. [email protected]
Pages 1339-1345 | Published online: 10 Jan 2014

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Maryam Saberi-Karimian, Niki Katsiki, Michele Caraglia, Mariarosaria Boccellino, Muhammed Majeed & Amirhossein Sahebkar. (2019) Vascular endothelial growth factor: An important molecular target of curcumin. Critical Reviews in Food Science and Nutrition 59:2, pages 299-312.
Read now
Nathan Steinle, Mark Barakat, Darius Moshfeghi & Peter K Kaiser. (2011) Radiation therapy in the treatment of exudative age-related macular degeneration. Expert Review of Ophthalmology 6:3, pages 323-337.
Read now
Jenia Jenab-Wolcott & Bruce J Giantonio. (2009) Bevacizumab: current indications and future development for management of solid tumors. Expert Opinion on Biological Therapy 9:4, pages 507-517.
Read now

Articles from other publishers (29)

J. Alejandro Perez-Fidalgo, Francisco Grau, Lorena Fariñas & Ana Oaknin. (2021) Systemic treatment of newly diagnosed advanced epithelial ovarian cancer: From chemotherapy to precision medicine. Critical Reviews in Oncology/Hematology 158, pages 103209.
Crossref
Christina R. Washington, Debra L. Richardson, Amma F. Agyemang, Kunle O. Odunsi & Kathleen N. Moore. 2021. Overcoming Ovarian Cancer Chemoresistance. Overcoming Ovarian Cancer Chemoresistance 129 149 .
Robert Cornelison, Danielle Llaneza & Charles Landen. (2017) Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review. International Journal of Molecular Sciences 18:10, pages 2171.
Crossref
Melissa K. Brunckhorst, Yin Xu, Rong Lu & Qin Yu. (2014) Angiopoietins Promote Ovarian Cancer Progression by Establishing a Procancer Microenvironment. The American Journal of Pathology 184:8, pages 2285-2296.
Crossref
S.H. Tirumani, A.B. Shinagare, J.P. Jagannathan, K.M. Krajewski & N.H. Ramaiya. (2014) Multidetector-row CT of tumour–bowel fistula: Experience at a tertiary cancer centre. Clinical Radiology 69:2, pages e100-e107.
Crossref
Madon M. Maile, Evelyn Y.T. Wong, Daphne Suzin, Nicole E. Birrer & Richard T. Penson. 2014. Anti-Angiogenesis Drug Discovery and Development. Anti-Angiogenesis Drug Discovery and Development 191 215 .
Elisabeth Smolle, Valentin Taucher, Martin Pichler, Edgar Petru, Sigurd Lax & Johannes Haybaeck. (2013) Targeting Signaling Pathways in Epithelial Ovarian Cancer. International Journal of Molecular Sciences 14:5, pages 9536-9555.
Crossref
M. Barakat, N. Steinle & P. K. Kaiser. 2013. Age-related Macular Degeneration. Age-related Macular Degeneration 247 261 .
Anna Klukovits, Andrew V. Schally, Luca Szalontay, Irving Vidaurre, Andrea Papadia, Marta Zarandi, Jozsef L. Varga, Norman L. Block & Gabor Halmos. (2011) Novel antagonists of growth hormone‐releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Cancer 118:3, pages 670-680.
Crossref
Edouard Lecarpentier, Lamia Ouaffi, Olivier Mir, Paul Berveiller, Melinda Maurel, Eric Pujade-Lauraine, Jean Luc Bouillot & Nicolas Veyrie. (2010) Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases. Investigational New Drugs 29:6, pages 1500-1503.
Crossref
David M. O'Malley, Debra L. Richardson, Patrick S. Rheaume, Ritu Salani, Eric L. Eisenhauer, Georgia A. McCann, Jeffrey M. Fowler, Larry J. Copeland, David E. Cohn & Floor J. Backes. (2011) Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecologic Oncology 121:2, pages 269-272.
Crossref
G. K. Siddiqui, A. B. Maclean, K. Elmasry, A. Wong te Fong, R. W. Morris, M. Rashid, R. H. J. Begent & G. M. Boxer. (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. Angiogenesis 14:2, pages 155-161.
Crossref
Naifu Liu, Xingwu Wang & Xiugui Sheng. (2011) ‘Triple negative’ epithelial ovarian cancer and pathologic markers for prognosis. Current Opinion in Obstetrics & Gynecology 23:1, pages 19-23.
Crossref
Anniina Färkkilä, Mikko Anttonen, Jurate Pociuviene, Arto Leminen, Ralf Butzow, Markku Heikinheimo & Leila Unkila-Kallio. (2011) Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors. European Journal of Endocrinology 164:1, pages 115-122.
Crossref
Maximilian Niyazi, Axel Siefert, Silke Birgit Schwarz, Ute Ganswindt, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn & Claus Belka. (2011) Therapeutic options for recurrent malignant glioma. Radiotherapy and Oncology 98:1, pages 1-14.
Crossref
Frank G. Holz, Daniel Pauleikhoff, Richard F. Spaide & Alan C. BirdMark R. Barakat, Nathan Steinle & Peter K. Kaiser. 2011. Altersabhängige Makuladegeneration. Altersabhängige Makuladegeneration 253 268 .
Nathan Steinle & Peter K. Kaiser. 2011. Age-related Macular Degeneration Diagnosis and Treatment. Age-related Macular Degeneration Diagnosis and Treatment 99 118 .
J. Tate Thigpen, David Alberts, Michael Birrer, Larry Copeland, Robert L. Coleman, Maurie Markman, Robert C. BastJrJr, Eric L. Eisenhauer, Gini Fleming, Paula M. Fracasso, David M. Gershenson, Thomas Herzog, Bradley J. Monk, Robert F. Ozols, Gordon Rustin, Mark F. Brady, Marissa Shrader & Aarati Ranganathan. (2010) Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer. Clinical Ovarian Cancer 3:2, pages 81-97.
Crossref
Jennifer Delli Carpini, Amer K. Karam & Leslie Montgomery. (2010) Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis 13:1, pages 43-58.
Crossref
Michelandrea De Cesare, Lucia Sfondrini, Manuela Campiglio, Michele Sommariva, Francesca Bianchi, Paola Perego, Nico van Rooijen, Rosanna Supino, Cristiano Rumio, Franco Zunino, Graziella Pratesi, Elda Tagliabue & Andrea Balsari. (2010) Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN. Journal of Immunotherapy 33:1, pages 8-15.
Crossref
Ernest S. Han & Bradley J. Monk. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 465 491 .
Daniel M. Birk, Joel Barbato, Leila Mureebe & Rabih A. Chaer. (2008) Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation. Vascular and Endovascular Surgery 42:6, pages 517-530.
Crossref
Emily K. Mader, Yoshihiro Maeyama, Yi Lin, Greg W. Butler, Holly M. Russell, Evanthia Galanis, Stephen J. Russell, Allan B. Dietz & Kah-Whye Peng. (2009) Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model. Clinical Cancer Research 15:23, pages 7246-7255.
Crossref
Helen X. Chen & Jessica N. Cleck. (2009) Adverse effects of anticancer agents that target the VEGF pathway. Nature Reviews Clinical Oncology 6:8, pages 465-477.
Crossref
K Engels, A du Bois, P Harter, A Fisseler-Eckhoff, F Kommoss, R Stauber, M Kaufmann, V Nekljudova & S Loibl. (2009) VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. Journal of Clinical Pathology 62:5, pages 448-454.
Crossref
Ernest S. Han, Paul Lin & Mark Wakabayashi. (2009) Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer. Current Treatment Options in Oncology 10:1-2, pages 54-66.
Crossref
GAURAV K. SHAH, DELIA N. SANG & MARK S. HUGHES. (2009) VERTEPORFIN COMBINATION REGIMENS IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina 29:2, pages 133-148.
Crossref
. (2009) Current World Literature. Current Opinion in Obstetrics & Gynecology 21:1, pages 101-109.
Crossref
Sarah BlagdenHani Gabra. (2008) Future directions in the management of epithelial ovarian cancer. Future Oncology 4:3, pages 403-411.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.